Parallax Volatility Advisers, L.P. Bristol Myers Squibb CO Call Options Transaction History

Parallax Volatility Advisers, L.P.

$45.1 Billion
Q2 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $26.1 Million - $34.3 Million	-647,900 Reduced 87.4%	93,400 $3.88 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $30 Million - $34 Million	-625,600 Reduced 45.77%	741,300 $40.2 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $18.2 Million - $21.8 Million	376,200 Added 37.97%	1,366,900 $70.1 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $39 Million - $43.6 Million	673,500 Added 212.33%	990,700 $57.5 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $62 Million - $68.8 Million	-973,100 Reduced 75.42%	317,200 $20.3 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $203 Million - $231 Million	-3,092,800 Reduced 70.56%	1,290,300 $89.4 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $149 Million - $176 Million	2,172,600 Added 98.29%	4,383,100 $315 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $54,184 - $32 Million	-416,800 Reduced 15.86%	2,210,500 $157 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $87.7 Million - $96.6 Million	1,207,900 Added 85.1%	2,627,300 $202 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $34.7 Million - $41.6 Million	564,200 Added 65.97%	1,419,400 $104 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $34.3 Million - $40 Million	639,700 Added 296.84%	855,200 $53.3 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $34.4 Million - $40.3 Million	-581,900 Reduced 72.97%	215,500 $12.8 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $4.49 Million - $4.89 Million	-72,500 Reduced 8.33%	797,400 $53.3 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $20.4 Million - $23 Million	-344,600 Reduced 28.37%	869,900 $54.9 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $28.6 Million - $32.4 Million	-494,700 Reduced 28.94%	1,214,500 $75.3 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $11.2 Million - $12.4 Million	195,100 Added 12.89%	1,709,200 $103 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $9.18 Million - $10.7 Million	-167,400 Reduced 9.96%	1,514,100 $89 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $20.3 Million - $29.6 Million	438,300 Added 35.26%	1,681,500 $93.7 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $1.53 Million - $2 Million	31,100 Added 2.57%	1,243,200 $79.8 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $35.4 Million - $42 Million	828,100 Added 215.65%	1,212,100 $61.5 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $42.7 Million - $47.2 Million	-956,700 Reduced 71.36%	384,000 $17.4 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $46.9 Million - $55.9 Million	1,038,500 Added 343.65%	1,340,700 $64 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $10.2 Million - $13.3 Million	210,200 Added 228.48%	302,200 $15.7 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $3.75 Million - $4.23 Million	-68,000 Reduced 42.5%	92,000 $5.71 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $33.6 Million - $41.9 Million	-664,700 Reduced 80.6%	160,000 $8.86 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $21 Million - $24.1 Million	349,700 Added 73.62%	824,700 $52.2 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $19.5 Million - $21.2 Million	325,000 Added 216.67%	475,000 $29.1 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $8.28 Million - $9.56 Million	150,000	150,000 $9.56 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account